Ex-10.2 Amendment to Stockholders Agreement

EX-10.2 2 b75905ctexv10w2.htm EX-10.2 AMENDMENT TO STOCKHOLDERS AGREEMENT exv10w2
Exhibit 10.2
AMENDMENT TO STOCKHOLDERS AGREEMENT
     This AMENDMENT TO STOCKHOLDERS AGREEMENT, dated as of June 26, 2009 (this “Amendment”), is by and among CHIESI FARMACEUTICI SPA, a corporation organized under the laws of Italy, CRAIG A. COLLARD, CORNERSTONE BIOPHARMA HOLDINGS, LTD., a limited liability company organized under the laws of Anguilla, CAROLINA PHARMACEUTICALS LTD., a limited liability company organized under the laws of Bermuda, LUTZ FAMILY LIMITED PARTNERSHIP, North Carolina limited partnership, STEVEN M. LUTZ and CORNERSTONE THERAPEUTICS INC., a Delaware corporation (the “Company”).
RECITALS
     WHEREAS, the parties entered into a Stockholders Agreement, dated as of May 6, 2009 (the “Stockholders Agreement”); and
     WHEREAS, the parties desire to amend the Stockholders Agreement in certain respects.
     NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:
     1. Annex A to the Stockholders Agreement is hereby deleted in its entirety and replaced with the Annex A attached hereto.
     2. This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
[Remainder of this page is intentionally left blank.]

 


 

     IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.
         
  CORNERSTONE THERAPEUTICS INC.
 
 
  By:   /s/ David Price   
    Name:   David Price  
    Title:   Chief Financial Officer  
 
  CHIESI FARMACEUTICI SPA
 
 
  By:   /s/ Alberto Chiesi   
    Name:   Alberto Chiesi  
    Title:   President  
 
[Signature Page to Amendment to Stockholders Agreement]

 


 

         
     
   /s/ Craig A. Collard    
  Craig A. Collard   
       
 
  CORNERSTONE BIOPHARMA HOLDINGS, LTD.
 
 
  By:   /s/ Craig A. Collard   
    Name:   Craig A. Collard  
    Title:   CEO  
 
  CAROLINA PHARMACEUTICALS LTD.
 
 
  By:   /s/ Craig A. Collard  
    Name:   Craig A. Collard  
    Title:   CEO  
 
[Signature Page to Amendment to Stockholders Agreement]

 


 

         
     
   /s/ Steven M. Lutz    
  Steven M. Lutz   
       
 
  LUTZ FAMILY LIMITED PARTNERSHIP
 
 
  By:   STEVEN M. LUTZ, its general partner    
       
   /s/ Steven M. Lutz    
  Steven M. Lutz   
       
 
[Signature Page to Amendment to Stockholders Agreement]

 


 

ANNEX A
COVERED SHARES
         
    Number of Covered
Stockholder   Shares
Craig A. Collard
    228,559  
Cornerstone Biopharma Holdings, Ltd.
    1,561,780  
Carolina Pharmaceuticals Ltd.
    947,207  
Lutz Family Limited Partnership
    261,878  
Steven M. Lutz
    195,227